(Q87271131)

English

A prospective study evaluating the clinical relevance of a chemoresponse assay for treatment of patients with persistent or recurrent ovarian cancer

scientific article published on 13 August 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23954900%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

A prospective study evaluating the clinical relevance of a chemoresponse assay for treatment of patients with persistent or recurrent ovarian cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23954900%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

based on heuristic

inferred from title

author name string

Thomas Rutherford

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23954900%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

James Orr

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23954900%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Edward Grendys

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23954900%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Robert Edwards

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23954900%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Thomas C Krivak

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23954900%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Robert Holloway

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23954900%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Richard G Moore

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23954900%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Larry Puls

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23954900%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Todd Tillmanns

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23954900%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Julian C Schink

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23954900%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Stacey L Brower

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23954900%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Chunqiao Tian

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23954900%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Thomas J Herzog

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23954900%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

13 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23954900%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23954900%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

131

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23954900%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23954900%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

362-367

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23954900%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.009

7 January 2021

A rational approach to the management of recurrent or persistent ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.009

7 January 2021

Evolution of platinum resistance in high-grade serous ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.009

7 January 2021

Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compounds

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.009

7 January 2021

Responses to salvage chemotherapy in ovarian cancer: a critical need for precise definitions of the treated population

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.009

7 January 2021

Association between in vitro platinum resistance in the EDR assay and clinical outcomes for ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.009

7 January 2021

Correlation of extreme drug resistant assay results and progression-free survival following intraperitoneal chemotherapy for advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.009

7 January 2021

Clinical relevance of extent of extreme drug resistance in epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.009

7 January 2021

Progression-free interval in ovarian cancer and predictive value of an ex vivo chemoresponse assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.009

7 January 2021

Extreme drug resistance assay does not influence survival in women with epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.009

7 January 2021

Low drug resistance to both platinum and taxane chemotherapy on an in vitro drug resistance assay predicts improved survival in patients with advanced epithelial ovarian, fallopian and peritoneal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.009

7 January 2021

Chemosensitivity and chemoresistance testing in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.009

7 January 2021

Point: chemosensitivity assays have a role in the management of recurrent ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.009

7 January 2021

Reporting recommendations for tumor marker prognostic studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.009

7 January 2021

The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.009

7 January 2021

Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.009

7 January 2021

A prospective randomized controlled trial of tumour chemosensitivity assay directed chemotherapy versus physician's choice in patients with recurrent platinum-resistant ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.009

7 January 2021

Evaluating the efficiency of targeted designs for randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.009

7 January 2021

Clinical trial designs for predictive marker validation in cancer treatment trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.009

7 January 2021

Randomized clinical trials with biomarkers: design issues

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.009

7 January 2021

Latest research and treatment of advanced-stage epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.009

7 January 2021

Recurrent ovarian cancer: how important is it to treat to disease progression?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.009

7 January 2021

A phase 3 trial of bevacizumab in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.009

7 January 2021

OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.009

7 January 2021

Incorporation of bevacizumab in the primary treatment of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.009

7 January 2021

Survival outcomes in patients with recurrent ovarian cancer who were treated with chemoresistance assay-guided chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.009

7 January 2021

Identifiers

10.1016/J.YGYNO.2013.08.009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23954900%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23954900%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q87271131&oldid=1755101297"